Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients

War in Ukraine: Current and future impacts on the Polish cancer care system

Biomedicine and the soul

Natural killer cells complexed with a bispecific antibody may provide new treatment option for patients with advanced lymphoma

Recent advances in the treatment of patients with exon 20 insertion-positive NSCLC

Intratumoral BO-112 with pembrolizumab shows benefit in advanced melanoma refractory to anti-PD-1 therapy

Recurrent non-invasive breast tumours may not always be related to the primary lesion

Safety and efficacy of olaparib plus metronomic cyclophosphamide and metformin in advanced/metastatic endometrial cancer

Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours

The adverse events atlas, towards a strategy to predict synergistic adverse events of combination therapies

Safety and efficacy of the oral ATR inhibitor elimusertib in advanced solid tumours with DNA damage response defects

PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/2, PALB2 or RAD51C/D mutations